Delivery Order SPE2DB20D9354-SPE2DB23FX7T3

Award Date 7/26/23
Potential Completion Date 8/16/23
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from August 29, 2023 through September 20, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing supplies, equipment, and weapon systems for the armed forces and other government...
The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from June 28, 2023 through July 20, 2023. As the DLA supports the logistical needs of the military services, this contract will likely deliver the pharmaceutical product to DOD medical treatment facilities and personnel within the...
The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
The Defense Logistics Agency (DOD) awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. No set aside designation or subcontractors were identified. The DLA supports the military services by providing nearly 100% of the consumable items needed to train, equip, and sustain...
The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The start date is July 6, 2023 and the end date is July 27, 2023. No set aside designation or subcontractors are indicated. The DLA procures and provides logistics support for medical supplies and equipment for the Department of Defense and other federal agencies, so this order is likely...
The Defense Logistics Agency (DOD) awarded a $77,370 delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The firm fixed price order is being performed in Park Ridge, Illinois under contract number 4561452920 from July 6th to July 27th, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies, likely including this order for the injectable medication Xolair...
The Defense Logistics Agency (DOD) awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
The Defense Logistics Agency awarded a delivery order valued at $11,605.50 to DMS Pharmaceutical Group Inc. to supply Xolair 75 MG/0.5 ML syringes. The firm fixed price order is for the delivery of 0.5mL syringes of Xolair to a location in Park Ridge, Illinois. Performance will take place between August 1st and August 22nd, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This...
The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
The Defense Logistics Agency awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561367155 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between June 26, 2023 and July 18, 2023. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other necessary supplies, this delivery order will provide the military with Xolair, a medication used to treat asthma and chronic idiopathic...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB23FX7T3
    Delivery Order

The Defense Logistics Agency (DOD) awarded a $8,123.85 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 26, 2023 through August 16, 2023. As the DLA supports the logistical needs of the military services, this contract for syringes of the medication Xolair is likely to support treatment of allergic or inflammatory conditions for military personnel under the DLA's medical supply chain responsibilities. No subcontractors or set aside designations were identified in the award information provided.

Generated 12/23/23, 6:34 AM